IVY DEEGAN: Open Payments
NPI 1356088272 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$732 in 36 payments from 10 companies in 2025. Trend: 2023 $701 · 2024 $715 · 2025 $732
Food & beverage: $630Education: $101
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $285 |
| E.R. Squibb & Sons, L.L.C. | 6 | $101 |
| Axsome Therapeutics, Inc. | 4 | $97 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Collegium Pharmaceutical, Inc. | 2 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Alkermes, Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
Products named: UZEDY, COBENFY, Auvelity, AUSTEDO XR, Jornay PM, REXULTI, INGREZZA, CAPLYTA.
Industry payments across PA — which companies pay providers there.
